Fortress Biotech, Inc. FBIO

2.28 0.00 0.00% as of 25 Sep
Market cap
$76.0M
P/E
0.7×
Growth Flags show if company had growth for consecutive years
Dec '16 Dec '17 Dec '18 Dec '19 Dec '20 Dec '21 Dec '22 Dec '23 Dec '24 Dec '25
P/E ratio
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
P/S ratio
6.79 9.84 1.39 3.84 5.01 2.97 0.76 0.26 0.73 1.61
P/FCF ratio
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
P/Operating CF
(6.23) (8.13) (1.69) (5.62) (11.15) (5.28) (1.21) (0.62) (3.27) (8.14)
P/B ratio
1.35 1.41 1.89 1.94 1.16 0.90 1.15 13.77 0.00 1.64
Price to Tangible BV
2.39 1.42 2.04 2.16 1.25 0.96 2.53 0.00 0.00 2.95
EV/Sales
2.82 5.10 0.55 2.60 1.24 (0.79) (0.32) 0.13 0.90 1.25
EV/EBITDA
0.00 0.00 0.00 0.00 0.00 0.30 0.13 0.00 0.00 0.00
EV/Operating CF
(1.01) (1.08) (0.15) (1.00) (0.68) 0.46 0.14 (0.09) (0.65) (1.20)
EV/FCF
(0.82) (1.03) (0.14) (0.90) (0.62) 0.41 0.12 (0.07) (0.44) (0.75)
Quick Ratio
1.77 1.95 1.63 3.32 4.99 3.26 1.62 1.13 0.95 2.20
Current Ratio
1.94 2.56 2.00 3.43 5.14 3.43 1.80 1.38 1.27 2.49
Net Debt/EBITDA
1.01 0.80 0.03 0.44 2.01 1.45 0.43 0.15 (0.01) 0.43
Debt/Assets
16.53% 25.41% 56.39% 40.38% 19.85% 11.95% 32.65% 36.33% 40.19% 28.25%
Debt/Equity
0.34 0.52 4.03 1.26 0.34 0.21 1.92 38.35 (35.26) 0.84
Asset Turnover
0.11 0.08 0.14 0.20 0.16 0.19 0.22 0.37 0.37 0.38
Operating CF/Net income
0.83 1.22 1.17 2.38 1.80 1.80 1.90 1.87 1.43 34.95
Capex/Depreciation
(3.81) (0.91) (2.09) (1.18) (0.65) (1.53) (0.26) (0.19) (1.60) 0.15
Interest Coverage
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
ROE
(65.89%) (65.74%) (120.00%) (86.61%) (34.52%) (30.60%) (68.58%) (266.13%) 177,428.57% (6.22%)
ROA
(38.08%) (32.10%) (43.49%) (21.75%) (16.62%) (17.73%) (27.39%) (29.74%) (35.86%) (1.14%)
ROIC
(210.59%) (107.83%) (464.85%) (255.54%) (197.50%) 0.00% 0.00% 0.00% 0.00% (124.61%)
Return on Tangible Assets
(91.15%) (56.26%) (124.46%) (32.47%) (20.56%) (24.84%) (81.74%) (177.81%) (251.39%) (2.46%)
Average Days of Receivables
192.44 177.28 103.10 143.53 197.49 126.23 136.60 66.46 65.83 172.75
Research and Development Expense of Revenue
213.19% 304.35% 325.06% 222.03% 140.59% 187.33% 178.07% 125.51% 98.62% 18.81%
Selling, General and Administrative Expense of Revenue
208.24% 295.14% 198.54% 151.76% 134.14% 126.24% 150.05% 107.65% 152.11% 152.38%
Intangible Assets out of Total Assets
0.21 0.00 0.01 0.03 0.04 0.03 0.09 0.12 0.22 0.15
Share Based Compensation of Revenue
83.80% 85.21% 67.38% 43.45% 32.53% 29.52% 30.35% 21.93% 56.75% 45.43%
Graham Net Nets
0.20 0.34 (0.27) 0.02 0.57 0.86 (0.24) (2.24) (1.32) 0.00
Graham Number
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 2.36 0.00
Earnings Yield
(48.90%) (39.54%) (263.32%) (27.22%) (20.18%) (31.58%) (149.16%) (338.45%) (154.23%) (2.19%)
Free Cash Flow Yield
(50.31%) (50.38%) (289.35%) (75.03%) (40.33%) (65.13%) (350.93%) (690.76%) (278.92%) (102.44%)
Revenue per Share
6.18 6.21 9.27 10.04 9.49 12.62 12.78 10.42 2.78 2.27
Operating CF per Share
(17.19) (29.26) (34.10) (26.02) (17.42) (21.39) (30.28) (15.81) (3.86) (2.36)
Capex per Share
(3.94) (1.44) (3.23) (2.57) (1.49) (3.00) (0.49) (0.26) (0.72) 0.04
Free Cash Flow per Share
(21.13) (30.70) (37.33) (28.60) (18.92) (24.39) (30.77) (16.07) (4.58) (2.32)
Cash per Share
34.40 47.13 28.67 37.50 48.59 56.11 30.09 9.98 2.76 2.85
Shareholders Equity per Share
31.13 43.37 6.81 19.88 41.02 41.45 8.44 0.20 (0.08) 2.23
Interest Debt per Share
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Book value per Share
31.13 43.37 6.81 19.88 41.02 41.45 8.44 0.20 (0.08) 2.23
Free Cash Flow
(56.32) (85.32) (108.20) (104.36) (90.85) (132.89) (182.33) (130.32) (95.19) (64.61)
Working Capital
53.07 111.74 55.59 110.64 214.39 245.42 102.72 32.11 18.97 74.10
Capital Expenditures
(10.50) (4.01) (9.36) (9.39) (7.16) (16.35) (2.93) (2.10) (15.00) 1.17
Net Current Asset Value
21.87 57.73 (10.04) 2.36 129.74 175.84 (13.84) (48.92) (55.50) 0.48
EV/EBIT
0.00 0.00 0.00 0.00 0.00 0.29 0.12 0.00 0.00 0.00
Capex to Sales
0.64 0.23 0.35 0.26 0.16 0.24 0.04 0.02 0.26 (0.02)
Net Profit Margin
(334.31%) (387.80%) (313.02%) (109.09%) (102.03%) (94.06%) (124.91%) (81.25%) (96.91%) (2.97%)
Price to Operating Income
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Other line items
Depreciation/Fixed assets
0.37 0.62 0.37 0.64 0.92 0.71 0.88 1.71 2.87 3.18
Cash ROIC
(26.22%) (28.16%) (60.80%) (35.70%) (19.25%) (22.73%) (59.32%) (93.97%) (73.47%) (35.21%)
Accounts Receivable Turnover
3.73 2.02 3.37 3.33 2.33 2.84 2.91 3.86 4.47 3.14
Accounts Payable Turnover
0.05 0.14 0.20 0.30 0.36 0.47 0.33 0.27 0.30 0.37
Inventory Turnover
4.22 19.56 14.43 13.72 12.91 5.70 2.56 1.88 1.69 1.74
Average Days of Payables
11,224.91 2,757.36 2,030.12 1,228.60 1,135.19 1,031.38 1,155.74 1,172.85 1,145.07 822.05
Days of Inventory on Hand
93.79 17.06 40.40 29.70 35.11 112.19 167.93 162.72 252.28 167.88
Average Receivables
4.42 8.53 7.98 11.00 19.54 24.23 26.07 21.87 12.90 20.17
Average Payables
17.37 25.96 30.85 34.76 40.42 68.02 94.05 85.50 69.53 56.31
Average Inventory
0.19 0.19 0.42 0.77 1.13 5.63 12.01 12.18 12.32 12.03
Average Assets
144.67 208.34 193.47 183.71 279.92 364.96 345.40 230.91 155.87 164.89
Average Common Equity
83.62 101.73 70.12 46.14 134.76 211.44 137.95 25.80 (0.03) 30.27

Fold the line items

Columns are period end dates